China FDA admits limits but solutions sketchy
This article was originally published in Scrip
Executive Summary
Drug companies in China have long been frustrated by lengthy processes to get new drugs approved and registered in the country, but such complaints appear to have been taken on board by the China Food and Drug Administration (CFDA) if new proposals are anything to go by.